Meryl Bartlett works with clients on a range of Food and Drug Administration (FDA), Federal Trade Commission (FTC), Federal Communications Commission (FCC), and Consumer Product Safety Commission (CPSC) regulatory matters. Meryl's experience includes counseling on risk management strategies, business growth opportunities, and responding to consumer class actions, federal and state regulatory enforcement actions, and competitor challenges. She has experience with pre-market and post-market compliance involving advertising and marketing of a broad range of consumer products, including human and pet foods, over-the-counter (OTC) drugs, dietary supplements, cosmetics, medical devices, personal care products, toys, and household electronics.
Meryl assists clients with compliance related to the full product life cycle, including product formulation and development, product classification, testing, claim substantiation, manufacturing, packaging, order fulfillment, and consumer or industry-facing marketing and promotional practices. She also counsels clients on monitoring and participating in agency rulemaking proceedings that impact their industries and potential business pathways in both the short and long term. On the technology side, these include FCC spectrum reallocation rulemakings, z-axis location accuracy requirements, and equipment authorization procedures. In the consumable and personal care product context, these include federal and state regulations on cannabis and cannabis-derived compounds, health and nutrition claims, and ingredient-specific labeling, including California's Proposition 65. Meryl also routinely advises clients on advertising and marketing compliance and tracks FTC enforcement, National Advertising Division (NAD) challenges, and the development of industry standards, including the Children's Advertising Review Unit (CARU) of the Better Business Bureau (BBB).